For pharmaceutical manufacturers, securing a dependable supply of high-quality intermediates is paramount. 11-alpha-Hydroxycarvenone (CAS 192569-17-8) stands out as a critical component, particularly in the synthesis of Eplerenone, a vital medication for cardiovascular health. This article aims to guide manufacturers through the essential considerations when sourcing this key pharmaceutical intermediate.

The chemical structure of 11-alpha-Hydroxycarvenone, with its specific molecular formula C22H28O4, is designed for efficient integration into complex drug synthesis pathways. The purity level, often specified at ≥99%, is a non-negotiable factor. Impurities, even in trace amounts, can significantly impact the final drug product's safety, efficacy, and regulatory approval. Therefore, understanding the 11-alpha-Hydroxycarvenone synthesis process and the quality control measures employed by suppliers is essential. Manufacturers should inquire about the analytical methods used to verify purity, such as HPLC.

The market for API intermediates for cardiovascular therapies is competitive, emphasizing the need for strategic sourcing. NINGBO INNO PHARMCHEM CO.,LTD. understands these demands and prioritizes the consistent supply of compounds like 11-alpha-Hydroxycarvenone. By partnering with experienced chemical suppliers, pharmaceutical companies can mitigate risks associated with supply chain disruptions and quality variations. For businesses looking to buy 11-alpha-Hydroxycarvenone, ensuring a transparent and robust supplier relationship is key to successful pharmaceutical intermediate manufacturing.